Pure Global AI
Committee for Medical and Pharmaceutical Control · structured requirements

🇰🇿 Kazakhstan IVD regulatory data

Explore the IVD requirements currently available for Kazakhstan, organized by topic and linked to official sources.

5 facts2 dimensions4 official sourceslatest verification 2026-09-15

Changes after registration in Kazakhstan

Source-linked rules for common changes to a registered IVD. Read the scope and conditions with each rule; unverified details are listed separately.

Does changing a device brand name or logo require an update?

A change to the registered brand name and a change to logo artwork can follow different rules. The legal manufacturer, device design and intended purpose remain the same.

A source-verified answer for this specific scenario is not yet published.

How do I update a manufacturer's name without changing the legal entity?

The same legal manufacturer changes its name, potentially alongside the device brand. A transfer to another legal entity is a separate question; permission to combine filings needs its own evidence.

A source-verified answer for this specific scenario is not yet published.

What changes when the manufacturer's office address changes?

An office address change for the same legal entity, potentially alongside name and brand changes. This does not cover moving a factory or manufacturing site, and a combined filing cannot be assumed.

A source-verified answer for this specific scenario is not yet published.

Does a catalogue or reference code change affect registration or UDI?

Check which identifier actually changes. A commercial catalogue, REF or order code is not automatically a device model, registered identifier, GTIN or UDI-DI. Rules for one identifier do not establish the route for another.

A source-verified answer for this specific scenario is not yet published.

Can several changes be filed together?

Changes to brand, manufacturer name, office address and reference codes may occur together, including with a real transfer to another legal manufacturer, registration holder or owner. Assess transfer with each single change, and transfer with brand plus reference, manufacturer name plus reference, or office address plus reference changes: seven transfer combinations in total. Evidence must establish the exact combination and the order of filings and approvals. These combinations and their sequence are not all verified by the rules below; a rule for one change does not prove that a single application, fee or review period covers the combination.

A source-verified answer for this specific scenario is not yet published.

Classification rules

What local class follows from which rules and decisive product facts?

Compare countries

Classification scheme (full axis)

classification.scheme-classes
Fact-level verified
Axis

Risk classes 1, 2a, 2b and 3 by degree of potential application risk (MoH Order No. ҚР ДСМ-281/2020).

Classes
  • Id

    1

    Label

    Class 1

    Normalized Risk Level

    low

  • Id

    2a

    Label

    Class 2a

    Normalized Risk Level

    medium

  • Id

    2b

    Label

    Class 2b

    Normalized Risk Level

    high

  • Id

    3

    Label

    Class 3

    Normalized Risk Level

    highest

Regulator

Ministry of Health

Notes
  • Medical devices including IVDs divide into 4 classes (1 low, 2а medium, 2б elevated, 3 high); the applicant determines the class per the annexed method; the class is fixed at state registration and each device belongs to only one class (paras 8, 10, 35-36; Chapter 3 for IVDs).
  • Special national rules: devices containing a nanomaterial class 3 (para 30); apheresis devices incl. sets, connectors and solutions class 3 (para 29); polymer blood containers class 2б; standalone software used with a device takes that device's class (paras 31, 33).
  • EAEU route: classification per the EAEU Rules approved by EEC Board Decision No. 173 of 22.12.2015; expertise must verify the class claimed by the applicant (Decision No. 46, rules para 23 item б).

Reliance & recognition

Which foreign decisions or evidence can be reused, with what effect and conditions?

Compare countries

Existing records include acceptance, restrictions and evidence reuse. The applicable product scope and conditions are preserved below; a reference does not by itself confer market access.

Kazakhstan approvals and evidence in other markets (0 records)

No linked record is currently maintained. This does not establish that a pathway is unavailable.

Prior approvals and evidence for Kazakhstan (4 records)

Prior approval / evidence record

China NMPA approval: origin evidence only

reliance.china-nmpa-origin-evidence
Pending verification
Statement

Under the national expertise rules, the registration dossier for any foreign-made device must contain a document certifying registration in the country of the manufacturer or production site (registration certificate, free-sale certificate or export certificate) with Kazakh and Russian translation. For a China-made device the NMPA registration certificate or NMPA-based export/free-sale certificate is that document; it triggers no abridged expertise.

Source Jurisdiction Id

china

Source Authority Id

nmpa

Source Approval

China NMPA medical device registration certificate (Class II/III) or Class I filing record

Target Jurisdiction Id

kazakhstan

China Classes In Scope

All classes (1, 2a, 2b, 3 and IVDs) under the national registration route

Edge Type

Origin Country Evidence

Market Access Strength

Evidence Only

Regulatory Layer

Product Marketing

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • Required (+) for classes 1, 2a, 2b, 3 and IVDs; exempt only for devices produced in Kazakhstan
  • Legalised per international and Kazakh attestation rules; authentic translation into Kazakh and Russian; PDF
  • Independent verification is incomplete. Treat this record as a research lead, not a confirmed benefit or exclusion; see the 2026-09-15 independent review.

Effective from 2021-02-06

Source passage: 1. Документ, удостоверяющий регистрацию в стране производителе или производственной площадке (регистрационное удостоверение, или Сертификат свободной продажи (FreeSale), или Сертификат на экспорт) с аутентичным переводом на казахский и русский языки (за исключением медицинских изделий, произведенных в Республике Казахстан) + + + + +

Prior approval / evidence record

China NMPA certificate: optional origin-registration item in the EAEU dossier

reliance.china-nmpa-origin-evidence-eaeu
Pending verification
Statement

The EAEU registration dossier includes, where available, a copy of the registration certificate (free-sale certificate or export certificate) issued in the manufacturer's country, and information on registration in other countries. An NMPA certificate for a China-made device is submitted under this item; it is optional ('при наличии') and does not shorten the EAEU expertise.

Source Jurisdiction Id

china

Source Authority Id

nmpa

Source Approval

China NMPA medical device registration certificate (Class II/III) or Class I filing record

Target Jurisdiction Id

kazakhstan

China Classes In Scope

All classes under the EAEU common registration route (Council Decision No. 46)

Edge Type

Origin Country Evidence

Market Access Strength

Evidence Only

Regulatory Layer

Product Marketing

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • Item is 'при наличии' (if available); export certificate not accepted for devices first produced in an EAEU member state
  • Applies identically in Russia, Belarus and Kazakhstan as reference or recognition states
  • Independent verification is incomplete. Treat this record as a research lead, not a confirmed benefit or exclusion; see the 2026-09-15 independent review.

Effective from 2016-02-12

Source passage: 10. Копия регистрационного удостоверения медицинского изделия (сертификата свободной продажи, сертификата на экспорт (за исключением медицинских изделий, впервые произведенных на территории государства-члена)), выданного в стране производителя (при наличии) ... 11. Сведения о регистрации в других странах ... или копия документа, удостоверяющего регистрацию медицинского изделия в других странах (при наличии)

KazakhstanEU conformity assessment

Prior approval / evidence record

CE Mark (EU MDR)

Authority

CE Mark (EU MDR)

Accepted

Yes

Benefit

Technical and QMS documentation can be reused, but the EAEU route requires its own national expertise. The 70 and 110 working-day service periods in Order ҚР ДСМ-10 do not change with origin.

Timeline Savings

None published

Maintained reference · planning ranges remain estimates · reviewed 2026-08-30

Related structured datasets

Classification systems · 1 record
Open Risk classes 1, 2a, 2b and 3 by degree of potential application risk (MoH Order No. ҚР ДСМ-281/2020). →
Id

kazakhstan:medical-device

Jurisdiction Id

kazakhstan

Domains
  • medical-device
  • ivd
Name

Risk classes 1, 2a, 2b and 3 by degree of potential application risk (MoH Order No. ҚР ДСМ-281/2020).

Classes
  • Id

    1

    Label

    Class 1

    Normalized Risk Level

    low

  • Id

    2a

    Label

    Class 2a

    Normalized Risk Level

    medium

  • Id

    2b

    Label

    Class 2b

    Normalized Risk Level

    high

  • Id

    3

    Label

    Class 3

    Normalized Risk Level

    highest

Regulator

Ministry of Health

Official Domains
  • adilet.zan.kz
  • gov.kz
Notes
  • Medical devices including IVDs divide into 4 classes (1 low, 2а medium, 2б elevated, 3 high); the applicant determines the class per the annexed method; the class is fixed at state registration and each device belongs to only one class (paras 8, 10, 35-36; Chapter 3 for IVDs).
  • Special national rules: devices containing a nanomaterial class 3 (para 30); apheresis devices incl. sets, connectors and solutions class 3 (para 29); polymer blood containers class 2б; standalone software used with a device takes that device's class (paras 31, 33).
  • EAEU route: classification per the EAEU Rules approved by EEC Board Decision No. 173 of 22.12.2015; expertise must verify the class claimed by the applicant (Decision No. 46, rules para 23 item б).
Source Status

official-source-verified

Source Title

Order of the Minister of Health No. ҚР ДСМ-281/2020, paras 8-36 and Annex

Source Url

https://adilet.zan.kz/rus/docs/V2000021808

Verified On

2026-08-25

Source Supports
  • class-axis
  • classification-rules
  • ivd-class-axis
Registration pathways, prior approvals and planning · 1 record

These country-level records can cover multiple product types. Check each item's scope and conditions before applying a fee, pathway or licence to an IVD.

Open Kazakhstan registration →
Country

Kazakhstan

Jurisdiction Id

kazakhstan

Country Code

KZ

Flag

🇰🇿

Regulator

Committee for Medical and Pharmaceutical Control of the Ministry of Healthcare

Regulator Abbrev

Committee for Medical and Pharmaceutical Control

Region

asia-pacific

Tier

3

Risk Classification

4-class (1, 2a, 2b, 3) — EAEU classification

Classes
  • Id

    class-1

    Class Name

    Class 1

    Risk Level

    low

    Pathway

    KMPC registration

    Official Timeline
    Min

    70

    Max

    70

    Unit

    working-days

    Realistic Timeline
    Min

    4

    Max

    6

    Unit

    months

    Notes
    • Portal service time 70 working days after +5 wd scheduling and a 2-wd completeness check (MoH Order No. 10, Annex 1)
    Clinical Trial Required

    No

    Local Testing Required

    Yes

    Gmp Required

    Yes

    Verification Status

    official-verified

    Official Source
    Title

    Kazakhstan Order ҚР ДСМ-10 annex — national expertise deadlines

    Url

    https://adilet.zan.kz/rus/docs/V2100022144

    Accessed Date

    2026-08-25

  • Id

    class-2a

    Class Name

    Class 2a

    Risk Level

    medium

    Pathway

    KMPC registration

    Official Timeline
    Min

    70

    Max

    70

    Unit

    working-days

    Realistic Timeline
    Min

    4

    Max

    6

    Unit

    months

    Notes
    • Portal service time 70 working days after +5 wd scheduling and a 2-wd completeness check (MoH Order No. 10, Annex 1)
    Clinical Trial Required

    No

    Local Testing Required

    Yes

    Gmp Required

    Yes

    Verification Status

    official-verified

    Official Source
    Title

    Kazakhstan Order ҚР ДСМ-10 annex — national expertise deadlines

    Url

    https://adilet.zan.kz/rus/docs/V2100022144

    Accessed Date

    2026-08-25

  • Id

    class-2b

    Class Name

    Class 2b

    Risk Level

    high

    Pathway

    KMPC registration

    Official Timeline
    Min

    110

    Max

    110

    Unit

    working-days

    Realistic Timeline
    Min

    7

    Max

    9

    Unit

    months

    Notes
    • Portal service time 110 working days after +5 wd scheduling and a 2-wd completeness check (MoH Order No. 10, Annex 1)
    Clinical Trial Required

    Yes

    Local Testing Required

    Yes

    Gmp Required

    Yes

    Verification Status

    official-verified

    Official Source
    Title

    Kazakhstan Order ҚР ДСМ-10 annex — national expertise deadlines

    Url

    https://adilet.zan.kz/rus/docs/V2100022144

    Accessed Date

    2026-08-25

  • Id

    class-3

    Class Name

    Class 3

    Risk Level

    highest

    Pathway

    KMPC registration

    Official Timeline
    Min

    110

    Max

    110

    Unit

    working-days

    Realistic Timeline
    Min

    8

    Max

    12

    Unit

    months

    Notes
    • Portal service time 110 working days after +5 wd scheduling and a 2-wd completeness check (MoH Order No. 10, Annex 1)
    Clinical Trial Required

    Yes

    Local Testing Required

    Yes

    Gmp Required

    Yes

    Verification Status

    official-verified

    Official Source
    Title

    Kazakhstan Order ҚР ДСМ-10 annex — national expertise deadlines

    Url

    https://adilet.zan.kz/rus/docs/V2100022144

    Accessed Date

    2026-08-25

Key Requirements
  • Local Authorized Representative (for foreign manufacturers)
  • Accelerated review and re-registration routes available within 30 working days
  • EAEU-route clocks: application acceptance 7 wd, completeness 3 wd, expertise 45 wd, decision 15 wd, certificate 5 wd, register entry 10 wd
  • In-country testing may be required depending on device type
Prior Approvals
  • Authority

    CE Mark (EU MDR)

    Accepted

    Yes

    Benefit

    Technical and QMS documentation can be reused, but the EAEU route requires its own national expertise. The 70 and 110 working-day service periods in Order ҚР ДСМ-10 do not change with origin.

    Timeline Savings

    None published

  • Authority

    FDA 510(k)/PMA

    Accepted

    Yes

    Benefit

    Usable as supporting technical evidence only. There is no recognition route and no published reduction.

    Timeline Savings

    None published

Local Rep Required

Yes

Local Rep Name

Kazakh Authorized Representative

Mdsap Accepted

No

Mdsap Benefit

Not accepted

Registration Validity

Indefinite (EAEU certificate)

Verification Status

official-verified

Official Sources
  • Title

    Kazakhstan Order ҚР ДСМ-10 annex — national expertise deadlines

    Url

    https://adilet.zan.kz/rus/docs/V2100022144

    Accessed Date

    2026-08-25

Reviewed On

2026-08-30

Last Updated

2026-08-30

Process
Template Id

default

Status

planning-template

Usage Rule

Maintained planning steps and estimates, not verified regulator deadlines.

Steps
  • Step

    1

    Title

    Pre-Submission Preparation

    Description

    Gather technical documentation, quality management system (QMS) records, and clinical data required by Committee for Medical and Pharmaceutical Control. Appoint a Kazakh Authorized Representative.

    Duration

    1-3 months

    Icon

    📋

  • Step

    2

    Title

    Application Submission

    Description

    Submit complete registration dossier to Committee for Medical and Pharmaceutical Control including device description, risk analysis, and testing reports.

    Duration

    1-2 weeks

    Icon

    📤

  • Step

    3

    Title

    Administrative Review

    Description

    Committee for Medical and Pharmaceutical Control reviews application for completeness. May request additional documents or clarifications.

    Duration

    2-4 weeks

    Icon

    🔍

  • Step

    4

    Title

    Technical Evaluation

    Description

    In-depth technical assessment of device safety and performance. Committee for Medical and Pharmaceutical Control may issue questions.

    Duration

    70 working days

    Icon

    ⚙️

  • Step

    5

    Title

    Registration Approval

    Description

    Upon successful review, Committee for Medical and Pharmaceutical Control issues Kazakhstan market authorization certificate.

    Duration

    1-2 weeks

    Icon

    ✅

Government fee schedules · 1 record

These country-level records can cover multiple product types. Check each item's scope and conditions before applying a fee, pathway or licence to an IVD.

Open Kazakhstan fees →
Jurisdiction Id

kazakhstan

Country

Kazakhstan

Country Code

KZ

Authority

Committee for Medical and Pharmaceutical Control

Low Risk Local
Min

0

Max

0

Currency

KZT

Per Product

Yes

High Risk Local
Min

0

Max

0

Currency

KZT

Per Product

Yes

Details
  • Id

    current-official-fee-status

    Item

    Registration fees expressed in monthly reference indices (MRP)

    Currency

    KZT

    Amount Local

    0

    Amount Local Formatted

    11 MRP registration / 5 MRP re-registration (KZT 47,575 / 21,625 in 2026)

    Frequency

    Check before submission

    Notes

    The current official service page states 11 MRP for state registration and 5 MRP for re-registration. The official 2026 MRP is KZT 4,325, giving KZT 47,575 and KZT 21,625 respectively.

    Amount Status

    formula-or-dynamic

    Verification Status

    official-source-only

    Source Url

    https://www.gov.kz/services/3769

    Source Title

    Kazakhstan digital-government service — state registration 11 MRP and re-registration 5 MRP

    Verified On

    2026-08-25

Notes
  • The current official service page states 11 MRP for state registration and 5 MRP for re-registration. The official 2026 MRP is KZT 4,325, giving KZT 47,575 and KZT 21,625 respectively.
  • The MRP value changes by financial year, so the formula is canonical and the tenge equivalents are explicitly 2026 values.
  • Expertise (review) work is charged per the NDDA price list on a non-cash basis, so MRP figures are not all-in totals.
Last Updated

2026-08-25

Verification Status

official-source-only

Official Sources
  • Title

    Kazakhstan digital-government service — state registration 11 MRP and re-registration 5 MRP

    Url

    https://www.gov.kz/services/3769

    Accessed Date

    2026-08-25

  • Title

    Kazakhstan 2026 statutory calculation indicators — MRP KZT 4,325

    Url

    https://www.gov.kz/article/17157?lang=ru

    Effective Date

    2026-01-01

    Accessed Date

    2026-08-25

  • Title

    Kazakhstan NDDA price list for medical-device expertise services

    Url

    https://old.ndda.kz/category/preiskurant_cen_mi

    Accessed Date

    2026-08-25

Reviewed On

2026-08-25

Amount Status

formula-or-dynamic

Range Available

No

Additional certifications and licences · 1 record

These country-level records can cover multiple product types. Check each item's scope and conditions before applying a fee, pathway or licence to an IVD.

Open Kazakhstan certifications →
Slug

kazakhstan

Market

Kazakhstan

Confidence

low

Schemes
  • Id

    registration-technical-and-biological-testing

    Name

    Registration technical and biological testing

    Category

    Medical Electrical Safety

    Status

    Included In Medical Registration

    Object

    Finished Device

    Note

    Health Code Art. 237: technical tests are performed by accredited organizations; EAEU-route dossiers additionally require biological-evaluation tests and clinical/clinical-laboratory trials plus type approval of measuring instruments (EAEU Decision № 42) per Decision 46 para 10. Classes 2б and 3 (and classes 1/2а when tests are needed) require laboratory tests within registration expertise (≤110 / ≤70 working days respectively); devices not requiring lab tests ≤70 working days.

    Source Urls
    • https://adilet.zan.kz/rus/docs/H16EV000046
    Source Binding

    candidate

  • Id

    measuring-instrument-state-register-entry

    Name

    Measuring-instrument state-register entry

    Category

    Legal Metrology

    Status

    Mandatory If Feature

    Object

    Measuring Instrument

    Note

    Health Code Art. 256 para 4: medical equipment that is a measuring instrument must be entered in the RK state register of the state system for ensuring the uniformity of measurements.

    Source Binding

    unresolved

Official Sources
  • Authority

    Adilet (Kazakhstan legal information system)

    Topic

    EAEU Decision 46 rules para 10 — technical tests, biological evaluation, measuring-instrument type approval

    Url

    https://adilet.zan.kz/rus/docs/H16EV000046

  • Authority

    Adilet (Kazakhstan legal information system)

    Topic

    state service requirements — laboratory-test timelines in registration expertise

    Url

    https://adilet.zan.kz/rus/docs/V2100022144

Keep researching this market
View the Kazakhstan resource hub →
DJ Fang
Need to apply Kazakhstan's requirements to a product?
Confirm the current Committee for Medical and Pharmaceutical Control pathway, evidence, and local-role details for the actual device before filing.
Pricing